# Immune Adsorption Role in Treatment of Resistant Lupus

> **NCT04108611** · NA · COMPLETED · sponsor: **Dr. Mohamed Ahmed El ghiriani** · enrollment: 90 (actual)

## Conditions studied

- Systemic Lupus

## Interventions

- **PROCEDURE:** hemodiafiltration with endogenous re infusion (HFR)

## Key facts

- **NCT ID:** NCT04108611
- **Lead sponsor:** Dr. Mohamed Ahmed El ghiriani
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-09-25
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04108611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04108611, "Immune Adsorption Role in Treatment of Resistant Lupus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04108611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*